Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Canagliflozin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Canagliflozin 300mg tablets
0601023AMAAABAB
|
Canagliflozin | Canagliflozin | Endocrine System | 87,054 |
|
Canagliflozin 100mg tablets
0601023AMAAAAAA
|
Canagliflozin | Canagliflozin | Endocrine System | 79,779 |
|
Invokana 300mg tablets
0601023AMBBABAB
|
Invokana | Canagliflozin | Endocrine System | 1,756 |
|
Invokana 100mg tablets
0601023AMBBAAAA
|
Invokana | Canagliflozin | Endocrine System | 1,357 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.